Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia, Myeloid, Acute 4Lymphoma, Non-Hodgkin 3Triple Negative Breast Neoplasms 2Multiple Myeloma 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell 2Lymphoma 2Glioblastoma 2Burkitt Lymphoma 2Sarcoma, Synovial 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neuroblastoma 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Liposarcoma, Myxoid 1Leukemia, Prolymphocytic, B-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1Leukemia 1Hodgkin Disease 1Hematologic Diseases 1Ganglioneuroblastoma 1Fallopian Tube Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Astrocytoma 1

Interventions

Rituximab 27acalabrutinib 15ibrutinib 13Cyclophosphamide 12Lenalidomide 10CT-P10 10zanubrutinib 9venetoclax 9Magnetic Resonance Spectroscopy 8obinutuzumab 7Specimen Handling 7Cytarabine 7Bendamustine Hydrochloride 7pirtobrutinib 6fludarabine 6Biopsy 6glofitamab 5fludarabine phosphate 5Peripheral Blood Stem Cell Transplantation 5Cyclosporine 5brexucabtagene autoleucel 4Whole-Body Irradiation 4Mycophenolic Acid 4Vincristine 3Stem Cell Transplantation 3Sirolimus 3Methotrexate 3Etoposide 3Doxorubicin 3Cyclosporins 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Mantle-Cell × Leukapheresis × 90 days × Clear all
NCT03623373 2026-04-21

Acalabrutinib With Bendamustine / Rituximab Followed by Cytarabine / Rituximab for Untreated Mantle Cell Lymphoma

Washington University School of Medicine

Phase 2 Completed
13 enrolled 13 charts
Lymphoid

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡